Enzyme replacement therapy in severe fabry with renal failure: A 1-year follow-up

Acta Dermato-Venereologica

Volumn 84, Issue 5, 2004, Pages 389-392

  Tsambaos, Dionysios ^a   Chroni, Elisabeth ^a   Manolis, Antonis S ^a   Monastirli, Alexandra ^a   Pasmatzi, Efi ^a   Sakkis, Theophilos ^a   Davlouros, Periklis ^a   Goumenos, Dimitrios ^a   Katrivanou, Aggeliki ^a   Georgiou, Sophia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

galactosidase A; Angiokeratoma; Depression; Dialysis; Diarrhoea; Globotriaosylceramides; Oedema

Indexed keywords

AGALSIDASE BETA; CETIRIZINE; NIMESULIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG RESPONSE; DRUG TOLERABILITY; ENZYME REPLACEMENT; FABRY DISEASE; FEVER; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RIGOR; SKIN MANIFESTATION; TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME;

ALPHA-GALACTOSIDASE; ENZYMES; FABRY DISEASE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 4744360911     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410030682     Document Type: Article

References (16)

1. Eng CM, Desnick RJ. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat 1994; 3: 103-111.
2. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramide-trihexosidase deficiency. N Engl J Med 1967; 276: 1163-1167.
3. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR et al, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001: 3733-3774.
4. Shiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, et al. Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 2000; 7: 365-370.
5. Eng CM, Banikazemi M, Gordon RE, Goldman M, Phelps R, Kim L, et al. A phase 1/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance and safety studies. Am J Hum Genet 2001; 68: 711-722.
6. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 9-16.
7. Schiffmann R, Kopp JB, Austin HA, Sabnis S, Moore DF, Weibel T, et al. Enzyme replacement therapy in Fabry disease. A randomized controlled trial. JAMA 2001; 285: 2743-2749.
8. Cariolou MA, Christodoulides M, Manoli P, Kokkofitou A, Tsambaos D. Novel trinucleotide deletion in Fabry's disease. Hum Genet 1996; 97: 468-470.
9. Monastirli A, Cariolou M, Michelakakis H, Pasmatzi E, Sakkis Th, Badavanis G, et al. A severe form of Anderson-Fabry disease associated with diffuse facial telangiectases and a new deletion of trinucleotide. Dermatopathology: Practical and Conceptual 2003; 9: 1-6.
10. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534.
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
12. Sung JH. Autonomic neurons affected by lipid storage in the spinal cord in Fabry's disease: distribution of autonomic neurons in the sacral cord. J Neuropathol Exp Neurol 1979; 2: 87-98.
13. O'Brien BD, Shnitka TK, McDougall R, Walker K, Costopoulos L, Lentle B, et al. Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease. Gastroenterology 1982; 82: 957-962.
14. Friedman LS, Kirkham SE, Thistlethwaite JR, Platika D, Kolodny EH, Schuffler MD. Jejunal diverticulosis with perforation as a complication of Fabry's disease. Gastroenterology 1984; 86: 558-563.
15. Said G, Boudier L, Selva J, Zingraff J, Drueke T. Different patterns of uremic polyneuropathy: clinicopathologic study. Neurology 1983; 33: 567-574.
16. Grewal RP. Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med 1993; 23: 307-312.